专注紧急救护远程会诊 SCO获华平3200万美元投资

2014-02-13 佚名 投资界

美国纽约,2014年2月11日消息,医疗机构Specialists On Call(简称“SOC”)宣布获得华平投资集团子公司投资3200万美元,SOC主要为紧急救护医院提供内科医生远程会诊服务。SOC成立于2007年,在美市场规模达30亿美元。SOC的服务除了帮助医院提升病人治疗水平外,还会加强社区医院的财务能力。公司独特的诊疗服务模式可望进一步扩大远程会诊市场规模,解决医院传统上应诊专科医生短

美国纽约,2014年2月11日消息,医疗机构Specialists On Call(简称“SOC”)宣布获得华平投资集团子公司投资3200万美元,SOC主要为紧急救护医院提供内科医生远程会诊服务。

SOC成立于2007年,在美市场规模达30亿美元。SOC的服务除了帮助医院提升病人治疗水平外,还会加强社区医院的财务能力。公司独特的诊疗服务模式可望进一步扩大远程会诊市场规模,解决医院传统上应诊专科医生短缺的问题。

华平董事总经理、全球医疗健康业投资负责人贝丝•韦瑟曼称:“远程会诊服务逐渐成为医院诊疗的主流服务方式,而SOC则专注于为城市和郊区紧急护理医院提供远程服务,这意味着公司未来将取得更大成功。”

截至目前,华平已投资了145家医疗健康类企业,投资额达85亿美元,其中包括博士伦等知名公司,以及国内知名民营医疗集团美中宜和等。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1706683, encodeId=195d1e06683a1, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sun Jun 29 23:07:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7993, encodeId=c006e99304, content=普及推广落到实处坚持做好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Sun Mar 02 19:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523168, encodeId=48d31523168c5, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 15 08:07:00 CST 2014, time=2014-02-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1706683, encodeId=195d1e06683a1, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sun Jun 29 23:07:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7993, encodeId=c006e99304, content=普及推广落到实处坚持做好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Sun Mar 02 19:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523168, encodeId=48d31523168c5, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 15 08:07:00 CST 2014, time=2014-02-15, status=1, ipAttribution=)]
    2014-03-02 112.65.244.92

    普及推广落到实处坚持做好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1706683, encodeId=195d1e06683a1, content=<a href='/topic/show?id=c7fd2582e4b' target=_blank style='color:#2F92EE;'>#会诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25827, encryptionId=c7fd2582e4b, topicName=会诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39df31305194, createdName=1249859em48(暂无昵称), createdTime=Sun Jun 29 23:07:00 CST 2014, time=2014-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=7993, encodeId=c006e99304, content=普及推广落到实处坚持做好, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=112.65.244.92, createdTime=Sun Mar 02 19:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523168, encodeId=48d31523168c5, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Sat Feb 15 08:07:00 CST 2014, time=2014-02-15, status=1, ipAttribution=)]